Stentys Reports 81% Year-over-Year Growth In Fourth-Quarter 2015 Revenues

PRINCETON, N.J. & PARIS--(BUSINESS WIRE)--Regulatory News:

STENTYS (Paris:STNT) (FR0010949404 — STNT), a medical technology company commercializing the world's first and only Self-Apposing® coronary stent, today announces its revenues for the fourth quarter and full year 2015.